We are dedicated to the discovery and implementation of new, cutting-edge technologies that enhance productivity of pharmaceutical drug discovery research. We believe that the best strategy through which to accomplish this goal is to invest in the innovation of the R&D processes and in better management of risks associated with early discovery research. Our proprietary technologies enable discovery of new medicines on the basis of principles that dictate molecular recognition between drugs and therapeutic targets, delivering targeted therapies which address the most pressing medical problems associated with cancer, drug-resistant bacterial infections and other diseases.
We value and reward individual and team contributions, foster creativity and risk taking, encourage diversity and equal employment opportunities. Our competitive advantage has been our tremendous intellectual capital and our focus on our employees is the key to our success.